Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
WARREN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 50,000...
Read More -
The revised valuation reflects growing institutional interest in gold-backed financial solutions and integrated digital infrastructure.
Read More
-
Aspo Plc ANNOUNCEMENT 19.12.2025 Aspo Plc: Share repurchase 19.12.2025 In the Helsinki Stock Exchange Trade date 19.12.2025 Bourse...
-
BTDR Investors Have Opportunity to Lead Bitdeer Technologies Group Securities Fraud Lawsuit with the Schall Law Firm
-
GAUZ Investors Have Opportunity to Lead Gauzy Ltd. Securities Fraud Lawsuit with the Schall Law Firm
GAUZ Investors Have Opportunity to Lead Gauzy Ltd. Securities Fraud Lawsuit with the Schall Law Firm
-
Den 23. oktober 2025 igangsatte Fast Ejendom Danmark A/S (”Selskabet”) et aktietilbagekøbsprogram. Aktietilbagekøbet løber i perioden fra og med den 24. oktober 2025 til og med den 23. oktober 2026....
-
RADNOR, Pa., Dec. 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed...
-
OWL Investors Have Opportunity to Lead Blue Owl Capital Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
FORT WAYNE, IN, Dec. 19, 2025 (GLOBE NEWSWIRE) -- FORT WAYNE, IN - December 19, 2025 - - What starts as a strange and satisfying moment, earwax falling out on its own, could be a warning sign...
-
ATLANTA, Dec. 19, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG). The lawsuit alleges that Defendants made...
-
HOUSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (“Salarius” or the “Company”) today announced that its 2025 Annual Meeting of Stockholders (the “Annual...
-
WARREN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has donated 50,000...